Filing Details

Accession Number:
0001567619-18-002466
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-12 19:16:36
Reporting Period:
2018-09-10
Accepted Time:
2018-09-12 19:16:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348911 Kalvista Pharmaceuticals Inc. KALV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207833 L Arnold Oronsky C/O Interwest
2710 Sand Hill Road 2Nd Floor
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-10 58,824 $17.00 388,766 No 4 P Indirect InterWest Partners IX, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect InterWest Partners IX, L.P.
Footnotes
  1. Shares held by InterWest Partners IX, L.P. is a California limited partnership ("InterWest"), whose general partner is InterWest Management Partners IX, LLC, a California limited liability company. Dr. Oronsky, one of the Company's directors, currently serves as a Managing Director of InterWest. Each managing director and venture member of InterWest Management Partners IX, LLC shares voting and investment power with respect to the securities held by InterWest and disclaims beneficial ownership of such shares except to the extent of his or her pecuniary interest therein.